These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 30681537)
1. ACOG Practice Bulletin No. 206 Summary: Use of Hormonal Contraception in Women With Coexisting Medical Conditions. Obstet Gynecol; 2019 Feb; 133(2):396-399. PubMed ID: 30681537 [TBL] [Abstract][Full Text] [Related]
2. ACOG Practice Bulletin No. 206: Use of Hormonal Contraception in Women With Coexisting Medical Conditions. Obstet Gynecol; 2019 Feb; 133(2):e128-e150. PubMed ID: 30681544 [TBL] [Abstract][Full Text] [Related]
3. ACOG Practice Bulletin. The use of hormonal contraception in women with coexisting medical conditions. Number 18, July 2000. ACOG Committee on Practice Bulletins-Gynecology Int J Gynaecol Obstet; 2001 Oct; 75(1):93-106. PubMed ID: 11732484 [TBL] [Abstract][Full Text] [Related]
4. Changes in US health care provider attitudes related to contraceptive safety before and after the release of National Guidance. Zapata LB; Morgan IA; Curtis KM; Folger SG; Whiteman MK Contraception; 2019 Nov; 100(5):413-419. PubMed ID: 31369735 [TBL] [Abstract][Full Text] [Related]
5. Canadian Contraception Consensus (Part 2 of 4). Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N J Obstet Gynaecol Can; 2015 Nov; 37(11):1033-9. PubMed ID: 26629725 [TBL] [Abstract][Full Text] [Related]
6. Canadian Contraception Consensus (Part 1 of 4). Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N; J Obstet Gynaecol Can; 2015 Oct; 37(10):936-42. PubMed ID: 26606712 [TBL] [Abstract][Full Text] [Related]
8. Hormonal contraception. ACOG Technical bulletin. Number 198-October 1994 (replaces No. 106, July 1987) American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet; 1995 Jan; 48(1):115-26. PubMed ID: 7698374 [TBL] [Abstract][Full Text] [Related]
9. Update to CDC's U.S. Medical Eligibility Criteria for Contraceptive Use, 2016: Revised Recommendations for the Use of Hormonal Contraception Among Women at High Risk for HIV Infection. Tepper NK; Krashin JW; Curtis KM; Cox S; Whiteman MK MMWR Morb Mortal Wkly Rep; 2017 Sep; 66(37):990-994. PubMed ID: 28934178 [TBL] [Abstract][Full Text] [Related]
10. Update to CDC's U.S. Medical Eligibility Criteria for Contraceptive Use, 2010: revised recommendations for the use of hormonal contraception among women at high risk for HIV infection or infected with HIV. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2012 Jun; 61(24):449-52. PubMed ID: 22717514 [TBL] [Abstract][Full Text] [Related]
12. Update to U.S. Medical Eligibility Criteria for Contraceptive Use, 2016: Updated Recommendations for the Use of Contraception Among Women at High Risk for HIV Infection. Tepper NK; Curtis KM; Cox S; Whiteman MK MMWR Morb Mortal Wkly Rep; 2020 Apr; 69(14):405-410. PubMed ID: 32271729 [TBL] [Abstract][Full Text] [Related]
13. ACOG practice bulletin. No. 73: Use of hormonal contraception in women with coexisting medical conditions. ACOG Committee on Practice Bulletins-Gynecology Obstet Gynecol; 2006 Jun; 107(6):1453-72. PubMed ID: 16738183 [No Abstract] [Full Text] [Related]
14. Conditions in rural Nepal for which depot-medroxyprogesterone acetate initiation is not recommended: implications for community-based service delivery. Rai C; Thapa S; Day J; Bhattarai L; McMullen S; Jha R; Shrestha S; Bastola S; Rivera R Contraception; 1999 Jul; 60(1):31-7. PubMed ID: 10549450 [TBL] [Abstract][Full Text] [Related]
15. Depot medroxyprogesterone acetate contraception in women with medical problems. Frederiksen MC J Reprod Med; 1996 May; 41(5 Suppl):414-8. PubMed ID: 8725704 [TBL] [Abstract][Full Text] [Related]
16. A review of the use of hormonal contraception in women with non-cardiovascular coexisting medical conditions. A comprehensive review. Feinberg T; Rougerie M; Dahan YS; Dahan MH Minerva Ginecol; 2020 Apr; 72(2):82-89. PubMed ID: 32186166 [TBL] [Abstract][Full Text] [Related]